News About: Pharm. Industry
Pfizer Korea promotes 2 senior managers to executivesPfizer Korea said Thursday that it promoted two senior managers, Lim Hyun-jung and Shin Kyun-ho, to new executives as of April 1.
Lim served as an U.S. certified public accou...
|
Hanmi wins local patent for manufacture of a combination form
Hanmi Pharmaceutical Co. said Wednesday that it won a Korean patent for manufacturing a combination form of irbersartan and atorvastatin.
The patent is characterized by adding a stabilizing agent in an effort to mi...
Generic substitution should be introduced to curb medication costs: NHIC report
Korea needs to consider introducing generic substitution to decrease insurance payouts for drug coverage, a report said Wednesday.
Without a wider use of generic drugs that can offer a safe, effective and low-cost ...
Leading drug makers seeking collaboration with multinational firms over OTC sales
With multinationals taking up three-quarters of the local prescription drug market, Korean drug companies are trying to survive the government’s price cuts by slashing production costs and collaborating with foreign c...
Menarini Korea starts marketing of PE drug Priligy
Menarini Korea can now resell its premature ejaculation (PE) treatment Priligy (dapoxetine) here after winning the rights to commercialize Priligy last year.
The Korean unit of Menarini Group, an international phar...
Patients with AMD benefits from extended health insurance coveragePatients with wet age-related macular degeneration (AMD) can now enjoy more extended health insurance coverage, according to the Ministry of Health and Welfare.
Under the rev...
|
NHI covers additional indications of RemicadeJanssen Korea said Wednesday that the additional indications of its TNF-alpha inhibitor Remicade, which was approved by the Korea Food and Drug Administration in 2000, has been ...
|
Drug makers to get heavier punishment over kickbacks
The government is stepping up its crackdown on the long-standing practice of offering and receiving kickbacks in the medical community. Yet it remains to be seen whether the illegal practice will be uprooted this time...
Daewoong benefits from strong sales force
Daewoong Pharmaceutical retains its strong marketing force with powerful brand image, data showed Tuesday.
Sales per capita by 15 listed pharmaceutical firms based on the sales of more than 200 billion won stood at...
Safety of herbal pills stirs controversy
The conflict between the government and oriental medicine doctors is resurfacing over the safety of newly-developed pills that contain herbal mixtures.
A local media reported Monday that six kinds of currently mark...
